nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.383	1	CbGbCtD
Epinephrine—Subarachnoid haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0427	0.168	CcSEcCtD
Epinephrine—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.0261	0.103	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0663	CcSEcCtD
Epinephrine—ADRBK1—peripheral nervous system—amyotrophic lateral sclerosis	0.0161	0.19	CbGeAlD
Epinephrine—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0142	0.056	CcSEcCtD
Epinephrine—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0479	CcSEcCtD
Epinephrine—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0456	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0406	CcSEcCtD
Epinephrine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00829	0.0327	CcSEcCtD
Epinephrine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00661	0.026	CcSEcCtD
Epinephrine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00616	0.0242	CcSEcCtD
Epinephrine—ADRBK1—embryo—amyotrophic lateral sclerosis	0.00589	0.0693	CbGeAlD
Epinephrine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00514	0.0202	CcSEcCtD
Epinephrine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00511	0.0201	CcSEcCtD
Epinephrine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.005	0.0197	CcSEcCtD
Epinephrine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0047	0.0185	CcSEcCtD
Epinephrine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00468	0.0184	CcSEcCtD
Epinephrine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00466	0.0183	CcSEcCtD
Epinephrine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00466	0.0183	CcSEcCtD
Epinephrine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00418	0.0165	CcSEcCtD
Epinephrine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0041	0.0161	CcSEcCtD
Epinephrine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00406	0.0477	CbGeAlD
Epinephrine—Tension—Riluzole—amyotrophic lateral sclerosis	0.004	0.0157	CcSEcCtD
Epinephrine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00396	0.0156	CcSEcCtD
Epinephrine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00374	0.0147	CcSEcCtD
Epinephrine—PAH—nervous system—amyotrophic lateral sclerosis	0.00371	0.0436	CbGeAlD
Epinephrine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0142	CcSEcCtD
Epinephrine—PAH—central nervous system—amyotrophic lateral sclerosis	0.00357	0.0419	CbGeAlD
Epinephrine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00352	0.0138	CcSEcCtD
Epinephrine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00347	0.0137	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00344	0.0136	CcSEcCtD
Epinephrine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00326	0.0128	CcSEcCtD
Epinephrine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00324	0.0128	CcSEcCtD
Epinephrine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0127	CcSEcCtD
Epinephrine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00321	0.0127	CcSEcCtD
Epinephrine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00312	0.0366	CbGeAlD
Epinephrine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0118	CcSEcCtD
Epinephrine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0118	CcSEcCtD
Epinephrine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00296	0.0116	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00287	0.0113	CcSEcCtD
Epinephrine—PAH—brain—amyotrophic lateral sclerosis	0.00283	0.0333	CbGeAlD
Epinephrine—ADRBK1—nervous system—amyotrophic lateral sclerosis	0.00283	0.0332	CbGeAlD
Epinephrine—ADRBK1—central nervous system—amyotrophic lateral sclerosis	0.00272	0.032	CbGeAlD
Epinephrine—ADRBK1—cerebellum—amyotrophic lateral sclerosis	0.00266	0.0313	CbGeAlD
Epinephrine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00866	CcSEcCtD
Epinephrine—ADRBK1—brain—amyotrophic lateral sclerosis	0.00216	0.0254	CbGeAlD
Epinephrine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00832	CcSEcCtD
Epinephrine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00778	CcSEcCtD
Epinephrine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00179	0.021	CbGeAlD
Epinephrine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00167	0.0196	CbGeAlD
Epinephrine—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00163	0.0192	CbGeAlD
Epinephrine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.0016	0.0188	CbGeAlD
Epinephrine—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00157	0.0184	CbGeAlD
Epinephrine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00127	0.015	CbGeAlD
Epinephrine—ADRA1D—brain—amyotrophic lateral sclerosis	0.00125	0.0146	CbGeAlD
Epinephrine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00123	0.0144	CbGeAlD
Epinephrine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00119	0.0139	CbGeAlD
Epinephrine—ADRB1—nervous system—amyotrophic lateral sclerosis	0.00118	0.0139	CbGeAlD
Epinephrine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00118	0.0139	CbGeAlD
Epinephrine—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.00114	0.0134	CbGeAlD
Epinephrine—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.00114	0.0134	CbGeAlD
Epinephrine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00106	0.0124	CbGeAlD
Epinephrine—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.00101	0.0119	CbGeAlD
Epinephrine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.000947	0.0111	CbGeAlD
Epinephrine—SLC22A1—brain—amyotrophic lateral sclerosis	0.000939	0.011	CbGeAlD
Epinephrine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.000936	0.011	CbGeAlD
Epinephrine—ADRB1—brain—amyotrophic lateral sclerosis	0.000905	0.0106	CbGeAlD
Epinephrine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000901	0.0106	CbGeAlD
Epinephrine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.000892	0.0105	CbGeAlD
Epinephrine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000881	0.0104	CbGeAlD
Epinephrine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.000858	0.0101	CbGeAlD
Epinephrine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.000844	0.00992	CbGeAlD
Epinephrine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000839	0.00986	CbGeAlD
Epinephrine—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.000804	0.00945	CbGeAlD
Epinephrine—ADRA1A—brain—amyotrophic lateral sclerosis	0.000715	0.00841	CbGeAlD
Epinephrine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000711	0.00836	CbGeAlD
Epinephrine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000685	0.00805	CbGeAlD
Epinephrine—ADRA2C—brain—amyotrophic lateral sclerosis	0.000682	0.00801	CbGeAlD
Epinephrine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00067	0.00787	CbGeAlD
Epinephrine—SLC22A5—brain—amyotrophic lateral sclerosis	0.000653	0.00767	CbGeAlD
Epinephrine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00056	0.00658	CbGeAlD
Epinephrine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000544	0.00639	CbGeAlD
Epinephrine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000539	0.00634	CbGeAlD
Epinephrine—ADRA2C—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	8.84e-05	0.000318	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.77e-05	0.000315	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.76e-05	0.000315	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	8.7e-05	0.000313	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.69e-05	0.000312	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	8.61e-05	0.000309	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.58e-05	0.000308	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.57e-05	0.000308	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.54e-05	0.000307	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—CHAT—amyotrophic lateral sclerosis	8.52e-05	0.000306	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.48e-05	0.000305	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.45e-05	0.000304	CbGpPWpGaD
Epinephrine—PAH—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.44e-05	0.000304	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	8.43e-05	0.000303	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GSR—amyotrophic lateral sclerosis	8.43e-05	0.000303	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	8.41e-05	0.000303	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.38e-05	0.000301	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.36e-05	0.0003	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	8.33e-05	0.0003	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.24e-05	0.000297	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	8.22e-05	0.000295	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.16e-05	0.000294	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.11e-05	0.000292	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.98e-05	0.000287	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.98e-05	0.000287	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.96e-05	0.000286	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.82e-05	0.000281	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.78e-05	0.00028	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	7.78e-05	0.00028	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.72e-05	0.000278	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.71e-05	0.000277	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.7e-05	0.000277	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	7.63e-05	0.000275	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.63e-05	0.000274	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.61e-05	0.000274	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—IGF1—amyotrophic lateral sclerosis	7.55e-05	0.000272	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.53e-05	0.000271	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	7.35e-05	0.000264	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.32e-05	0.000263	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	7.26e-05	0.000261	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.2e-05	0.000259	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.18e-05	0.000258	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.12e-05	0.000256	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.1e-05	0.000255	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.1e-05	0.000255	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.09e-05	0.000255	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.09e-05	0.000255	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.06e-05	0.000254	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—IGF1—amyotrophic lateral sclerosis	7.05e-05	0.000254	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.05e-05	0.000254	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.01e-05	0.000252	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	6.92e-05	0.000249	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.87e-05	0.000247	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.81e-05	0.000245	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	6.8e-05	0.000245	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—MMP9—amyotrophic lateral sclerosis	6.7e-05	0.000241	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	6.65e-05	0.000239	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.59e-05	0.000237	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.56e-05	0.000236	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.49e-05	0.000234	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.43e-05	0.000231	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—PTGS2—amyotrophic lateral sclerosis	6.42e-05	0.000231	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.4e-05	0.00023	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.38e-05	0.000229	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.3e-05	0.000226	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.29e-05	0.000226	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.26e-05	0.000225	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.24e-05	0.000224	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.23e-05	0.000224	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.2e-05	0.000223	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.13e-05	0.00022	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.04e-05	0.000217	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	6.02e-05	0.000216	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.96e-05	0.000214	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.9e-05	0.000212	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.86e-05	0.000211	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.85e-05	0.00021	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.8e-05	0.000209	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.8e-05	0.000208	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.79e-05	0.000208	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	5.73e-05	0.000206	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.7e-05	0.000205	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.69e-05	0.000205	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.68e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.66e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.63e-05	0.000203	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.56e-05	0.0002	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	5.44e-05	0.000196	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.44e-05	0.000196	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.42e-05	0.000195	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.29e-05	0.00019	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.27e-05	0.000189	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.26e-05	0.000189	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.24e-05	0.000188	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.21e-05	0.000187	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.18e-05	0.000186	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.18e-05	0.000186	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.17e-05	0.000186	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.13e-05	0.000185	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.07e-05	0.000182	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.04e-05	0.000181	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.96e-05	0.000178	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.96e-05	0.000178	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.93e-05	0.000177	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.91e-05	0.000177	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.89e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.85e-05	0.000174	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.84e-05	0.000174	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.82e-05	0.000173	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.72e-05	0.00017	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.71e-05	0.000169	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.71e-05	0.000169	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.68e-05	0.000168	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.65e-05	0.000167	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.62e-05	0.000166	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.61e-05	0.000166	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.6e-05	0.000165	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.59e-05	0.000165	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.58e-05	0.000165	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.52e-05	0.000162	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.47e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.44e-05	0.00016	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.39e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.37e-05	0.000157	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.35e-05	0.000157	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.33e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.3e-05	0.000155	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.28e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.27e-05	0.000154	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.24e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.21e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.17e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.17e-05	0.00015	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.08e-05	0.000147	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.04e-05	0.000145	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.03e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.01e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.01e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.98e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.95e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.94e-05	0.000142	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.89e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.82e-05	0.000137	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.82e-05	0.000137	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.8e-05	0.000137	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.77e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.74e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.74e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.73e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	3.73e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.72e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.72e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.69e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.68e-05	0.000132	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.59e-05	0.000129	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.56e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.55e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.54e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.52e-05	0.000127	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.49e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	3.48e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.46e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	3.46e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.43e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.42e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.36e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.35e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.33e-05	0.00012	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.32e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.29e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.27e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.17e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.13e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.11e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.1e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.08e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.06e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.06e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.04e-05	0.000109	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.95e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.89e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.86e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.85e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.84e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.84e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	2.83e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	2.81e-05	0.000101	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.79e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.72e-05	9.77e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.68e-05	9.63e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.58e-05	9.29e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.56e-05	9.21e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.53e-05	9.1e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.53e-05	9.09e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.53e-05	9.08e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.44e-05	8.77e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.4e-05	8.64e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.39e-05	8.6e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.39e-05	8.59e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.37e-05	8.53e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.35e-05	8.47e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.35e-05	8.46e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.27e-05	8.17e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.21e-05	7.94e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.18e-05	7.85e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.15e-05	7.73e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.09e-05	7.52e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.06e-05	7.42e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.05e-05	7.38e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.99e-05	7.15e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.97e-05	7.09e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.95e-05	7e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.94e-05	6.99e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.93e-05	6.93e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.89e-05	6.78e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.88e-05	6.76e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.86e-05	6.7e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.85e-05	6.66e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.84e-05	6.62e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.84e-05	6.61e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.82e-05	6.53e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.81e-05	6.52e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.74e-05	6.26e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.71e-05	6.16e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.69e-05	6.07e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.67e-05	6.01e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.65e-05	5.94e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.61e-05	5.79e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.58e-05	5.7e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.56e-05	5.62e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.55e-05	5.58e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.54e-05	5.53e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.52e-05	5.47e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.5e-05	5.38e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.46e-05	5.24e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.41e-05	5.08e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.4e-05	5.03e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.37e-05	4.91e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.28e-05	4.59e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.27e-05	4.56e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.26e-05	4.54e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.25e-05	4.49e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.24e-05	4.48e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.2e-05	4.31e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.18e-05	4.25e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.16e-05	4.18e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.06e-05	3.82e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.03e-05	3.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.59e-06	3.45e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.21e-06	2.95e-05	CbGpPWpGaD
